3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
35
Advanced Solid Tumors
20
Carcinoma, Non-Small-Cell Lung
14
Myelodysplastic Syndromes
13
Breast Neoplasms
13
Advanced Solid Tumor
13
Recurrence
10
Ovarian Neoplasms
8
Neoplasms
8
Multiple Myeloma
8
Leukemia, Myelomonocytic, Chronic
8
Triple Negative Breast Neoplasms
7
Solid Tumor
6
Myeloproliferative Disorders
6
Small Cell Lung Carcinoma
5
Prostatic Neoplasms
5
Neoplasm Metastasis
5
Lung Neoplasms
5
Carcinoma, Hepatocellular
5
Advanced Solid Tumour
5
Sarcoma
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Melanoma
4
Lymphoma, Large B-Cell, Diffuse
4
Lymphoma, B-Cell
4
Fallopian Tube Neoplasms
4
Colorectal Neoplasms
4
Advanced Malignant Solid Tumor
4
Advanced Lung Cancer
4
Squamous Cell Carcinoma of Head and Neck
3
Interventions
Gemcitabine
15
Cisplatin
15
pembrolizumab
9
Oxaliplatin
7
durvalumab
5
Leucovorin
5
Fluorouracil
5
130-nm albumin-bound paclitaxel
5
Platinum
4
Albumin-Bound Paclitaxel
4
1,2-diaminocyclohexaneplatinum II citrate
4
Trastuzumab
3
Taxes
3
Specimen Handling
3
Magnetic Resonance Spectroscopy
3
Capecitabine
3
zanidatamab
2
fludarabine
2
Paclitaxel
2
Nivolumab
2
Folfox protocol
2
Docetaxel
2
Cyclophosphamide
2
Biopsy
2
tucatinib
1
trifluridine tipiracil drug combination
1
trastuzumab deruxtecan
1
tivozanib
1
pertuzumab
1
peposertib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Gallbladder Neoplasms
×
Injections
×
1 year
×
Clear all
No trials found.